BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 38005222)

  • 1. Two-Dimensional-PAGE Coupled with nLC-MS/MS-Based Identification of Differentially Expressed Proteins and Tumorigenic Pathways in MCF7 Breast Cancer Cells Transfected for JTB Protein Silencing.
    Jayathirtha M; Jayaweera T; Whitham D; Sullivan I; Petre BA; Darie CC; Neagu AN
    Molecules; 2023 Nov; 28(22):. PubMed ID: 38005222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-Dimensional Polyacrylamide Gel Electrophoresis Coupled with Nanoliquid Chromatography-Tandem Mass Spectrometry-Based Identification of Differentially Expressed Proteins and Tumorigenic Pathways in the MCF7 Breast Cancer Cell Line Transfected for Jumping Translocation Breakpoint Protein Overexpression.
    Jayathirtha M; Jayaweera T; Whitham D; Petre BA; Neagu AN; Darie CC
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating the Function of Human Jumping Translocation Breakpoint Protein (hJTB) and Its Interacting Partners through In-Solution Proteomics of MCF7 Cells.
    Jayathirtha M; Whitham D; Alwine S; Donnelly M; Neagu AN; Darie CC
    Molecules; 2022 Nov; 27(23):. PubMed ID: 36500393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the effects of overexpression of jumping translocation breakpoint (JTB) protein in MCF7 cells for potential use as a biomarker in breast cancer.
    Jayathirtha M; Neagu AN; Whitham D; Alwine S; Darie CC
    Am J Cancer Res; 2022; 12(4):1784-1823. PubMed ID: 35530281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the effects of downregulation of jumping translocation breakpoint (JTB) protein expression in MCF7 cells for potential use as a biomarker in breast cancer.
    Jayathirtha M; Neagu AN; Whitham D; Alwine S; Darie CC
    Am J Cancer Res; 2022; 12(9):4373-4398. PubMed ID: 36225631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HBsAg inhibits the translocation of JTB into mitochondria in HepG2 cells and potentially plays a role in HCC progression.
    Liu YP; Yang XN; Jazag A; Pan JS; Hu TH; Liu JJ; Guleng B; Ren JL
    PLoS One; 2012; 7(5):e36914. PubMed ID: 22615844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic analysis of inhibitor of apoptosis protein‑like protein‑2 on breast cancer cell proliferation.
    Xiang S; Zhu L; Zhang Z; Wang S; Cui R; Xiang M
    Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35039877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics analysis of human breast milk by two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) coupled with mass spectrometry to assess breast cancer risk.
    Aslebagh R; Whitham D; Channaveerappa D; Lowe J; Pentecost BT; Arcaro KF; Darie CC
    Electrophoresis; 2023 Jul; 44(13-14):1097-1113. PubMed ID: 36971330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentially Expressed Mitochondrial Proteins in Human MCF7 Breast Cancer Cells Resistant to Paclitaxel.
    Daniel P; Halada P; Jelínek M; Balušíková K; Kovář J
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31248089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulated GBX2 gene suppresses proliferation, invasion and angiogenesis of breast cancer cells through inhibiting the Wnt/β-catenin signaling pathway.
    Fang Y; Yuan Y; Zhang LL; Lu JW; Feng JF; Hu SN
    Cancer Biomark; 2018; 23(3):405-418. PubMed ID: 30223390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of proteins responsible for adriamycin resistance in breast cancer cells using proteomics analysis.
    Wang Z; Liang S; Lian X; Liu L; Zhao S; Xuan Q; Guo L; Liu H; Yang Y; Dong T; Liu Y; Liu Z; Zhang Q
    Sci Rep; 2015 Mar; 5():9301. PubMed ID: 25818003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
    Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of genes and pathways associated with MDR in MCF-7/MDR breast cancer cells by RNA-seq analysis.
    Yang M; Li H; Li Y; Ruan Y; Quan C
    Mol Med Rep; 2018 May; 17(5):6211-6226. PubMed ID: 29512753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative Proteomic Analysis of Porcine Intestinal Epithelial Cells Infected with Porcine Deltacoronavirus Using iTRAQ-Coupled LC-MS/MS.
    Zhou X; Zhou L; Ge X; Guo X; Han J; Zhang Y; Yang H
    J Proteome Res; 2020 Nov; 19(11):4470-4485. PubMed ID: 33045833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Jumping translocation breakpoint (JTB) gene product isolated as a TGF-beta1-inducible clone involved in regulation of mitochondrial function, cell growth and cell death.
    Kanome T; Itoh N; Ishikawa F; Mori K; Kim-Kaneyama JR; Nose K; Shibanuma M
    Oncogene; 2007 Sep; 26(41):5991-6001. PubMed ID: 17369841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells.
    Li JP; Yang YX; Liu QL; Zhou ZW; Pan ST; He ZX; Zhang X; Yang T; Pan SY; Duan W; He SM; Chen XW; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1027-62. PubMed ID: 25733818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentially expressed proteins in ER+ MCF7 and ER- MDA- MB-231 human breast cancer cells by RhoGDI-α silencing and overexpression.
    Hooshmand S; Ghaderi A; Yusoff K; Thilakavathy K; Rosli R; Mojtahedi Z
    Asian Pac J Cancer Prev; 2014; 15(7):3311-7. PubMed ID: 24815488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of STAT3, β-Catenin, and Notch-1 by Single and Combinations of siRNA Treatment Enhance Chemosensitivity of Wild Type and Doxorubicin Resistant MCF7 Breast Cancer Cells to Doxorubicin.
    Alshaer W; Alqudah DA; Wehaibi S; Abuarqoub D; Zihlif M; Hatmal MM; Awidi A
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCAT2 knockdown inhibits cell growth, and migration and promotes apoptosis through regulating the hsa-mir-145-5p/AKT3/mTOR axis in tamoxifen-resistant MCF7 cells.
    Moradi F; Mohajerani F; Sadeghizadeh M
    Life Sci; 2022 Dec; 311(Pt B):121183. PubMed ID: 36375570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular mechanisms of resistance to phosphatidyl inositol 3-kinase inhibitors in triple-negative breast cancer cells].
    Zhang WL; Ma WJ; Chen S; Wu XZ; Zhang HR; Zhang JH
    Zhonghua Zhong Liu Za Zhi; 2016 Aug; 38(8):578-88. PubMed ID: 27531477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.